Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
BrightPath Biotherapeutics Co., Ltd. 4594
| Cost of capital | no mention | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | names a metric 「なお、研究開発型の創薬ベンチャーは、研究開発投資からライセンスアウトによる収益化までの長期間に及ぶ事業サイクルが、開発パイプライン複数個によって資産(企業価値を構成するソフトな資産)構成されるため、売上高や当期純損益や、ROE、ROAといった年単位で見る指標は、適切な経営指標となりにくいと考えております」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Target | no numeric target | matched by rule |
| Payout | no return language | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names